AssureRx Health, Inc. announced that it has appointed Stephen Stamp as Senior Vice President & CFO and Jeffrey Bush as Vice President, Payer Markets and Reimbursement to its leadership team.
The appointments coincide with increasing demand for GeneSight pharmacogenomic testing services, which support healthcare providers in medication selection and the management of side effects for patients with neuropsychiatric and other disorders, the company said.
The company stated that Stephen Stamp is responsible for all financial matters at Assurex Health, including financing strategy and implementation, accounting, tax, M&A activities, and government contracting.
Commenting on Stephen, Assurex Health said he joins the company with 30 years of experience in finance, accounting, business development and operations. He has worked in multiple public and venture-backed companies both in the US and the UK, including business to consumer, business to business, and pharmaceutical industries. Stephen has served as Chief Financial Officer of EZCORP, Inc. (EZPW), a consumer financial services company; Chief Operating Officer, Chief Financial Officer, and Executive Vice President Business Development at Xanodyne Pharmaceuticals, Inc., a specialty pharmaceutical company; Group Finance Director at Regus PLC, a serviced office accommodations business; and Group Finance Director at Shire PLC, a specialty pharmaceutical company focusing on ADHD and other specialty medications.
For comments and feedback: editorial@rttnews.com